Medical Journals

Recombinant Human Erythropoietin Suppresses Symptom Onset and Progression of G93a-sod1 Mouse Model of Als by Preventing Motor Neuron Death and Inflammation.

Authors:
  • Koh Seong-Ho
  • Kim Youngchul
  • Kim Hyun Young
  • Cho Goang Won
  • Kim Kyung Sook
  • Kim Seung H

From: Department of Neurology, College of Medicine, Hanyang University, Seoul, Korea.

The European journal of neuroscience

  • Publish Date: Apr 2007
  • ISSN: 0953-816X
  • Volume: 25
  • Issue: 7
  • Pages: 1923-30
  • Medium: Print
  • Language: English
  • Citation (JAMA): Koh Seong-Ho, Kim Youngchul, Kim Hyun Young, et al. Recombinant Human Erythropoietin Suppresses Symptom Onset and Progression of G93a-sod1 Mouse Model of Als by Preventing Motor Neuron Death and Inflammation.. Eur. J. Neurosci. Apr 2007;25:1923-30

Abstract

Multifactorial pathogenic mechanisms, including inflammation, attenuated survival signals and enhanced death signals, are involved in amyotrophic lateral sclerosis (ALS). Erythropoietin (EPO) has recently been highlighted as a cytokine with various potent neuroprotective effects, including reduction of inflammation, enhancement of survival signals and prevention of neuronal cell death. This study was undertaken to evaluate the effect of recombinant human EPO (rhEPO) on ALS model mice. We treated 96 ALS model mice with vehicle only, or 1, 2.5 or 5 imu of rhEPO/g of mouse once every other week after they were 60 days old. The treatment significantly prolonged symptom onset and life span, preserved more motor neurons, enhanced survival signals, and attenuated inflammatory signals in a dose-dependent manner. These data suggest that treatment with rhEPO represents a potential therapeutic strategy for ALS.

Mesh Headings (Keywords): Amyotrophic Lateral Sclerosis, Animals, Dinoprostone, Disease Models, Animal, Disease Progression, Erythropoietin, Recombinant, Humans, Inflammation, Mice, Mice, Transgenic, Motor Neurons, Rotarod Performance Test, Spinal Cord, Superoxide Dismutase, Survival Rate


Check for Full Text / PubMed Unique Identifier (PMID): 17439481


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.